Literature DB >> 19621520

[Characteristics of vibration response imaging in chronic obstructive pulmonary disease].

Jun Li1, Bai-Qiang Cai.   

Abstract

OBJECTIVE: To explore the characteristics of vibration response imaging (VRI) in chronic obstructive pulmonary disease (COPD).
METHODS: Sixty-three COPD patients received lung function test (LFT) and VRI examination before and after inhalation of bronchodilator. As the control group, 66 healthy volunteers received LFT and VRI examinations. We defined VRI results as quantitative lung data (QLD), crack counts, and image grade.
RESULTS: The results of control group were: QLD of right lung (45.1 +/- 5.9%), mean crack counts 0.1, and mean image grade 0.9. After inhalation of bronchodilator, the VRI results of COPD group were: QLD of right lung (51.0 +/- 12.1)%, mean crack counts 2.7, and image grade 4.2 +/- 1.9. The results between control group and COPD group were significantly different (P < 0.01). The VRI results were similar before and after inhalation of bronchodilator in COPD group (P > 0.05). After inhalation of bronchodilator, there was a linear relationship between VRI image grade and FEV1% (r = 0.31, P = 0.01). The model of the linear regression was: y = 63.85 -2.95 x (y: 100 x FEV1%, x: VRI image grade).
CONCLUSIONS: The VRI results differ between COPD patients and healthy people. The VRI results are stable after inhalation of bronchodilator in COPD patients, which may be helpful in the diagnosis of COPD. The VRI image grade after inhalation of bronchodilator is useful to assess the degree of obstruction.

Entities:  

Mesh:

Year:  2009        PMID: 19621520

Source DB:  PubMed          Journal:  Zhongguo Yi Xue Ke Xue Yuan Xue Bao        ISSN: 1000-503X


  1 in total

1.  Application of vibration response imaging technology in patients with community-acquired pneumonia before and after the treatment.

Authors:  Hongying Jiang; Jichao Chen; Jinying Cao; Lan Mu; Zhenyu Hu; Jian He
Journal:  Exp Ther Med       Date:  2017-05-03       Impact factor: 2.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.